Financial Synergies Wealth Advisors, Inc. Alkermes Plc. Transaction History
Financial Synergies Wealth Advisors, Inc.
- $742 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
178MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$813 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$562 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$415 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$251 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$232 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.58B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...